ArticleArchives of orthopaedic and trauma surgery2025
Prospective comparative study of scaphocapitate arthrodesis with and without lunate excision for stage IIIB Kienböck's disease.
Article in Archives of orthopaedic and trauma surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionKienböck's disease is a progressive avascular necrosis of the lunate that causes wrist pain and functional impairment. Surgical intervention is often needed for advanced stage IIIB disease to relieve symptoms and preserve the carpal structure. Scaphocapitate (SC) arthrodesis is an established technique, but the value of lunate excision versus preservation remains debated. This study prospectively compared the outcomes of SC arthrodesis performed with and without lunate excision. MATERIALS AND
methodsThis prospective comparative study included 38 patients with stage IIIB Kienböck's disease, who were allocated to receive SC arthrodesis with lunate preservation (n = 19) or lunate excision (n = 19). The follow-up time was 84 months. The primary outcome measure was pain intensity, which was assessed via the visual analogue scale (VAS) for pain. The secondary outcomes included wrist function evaluated by the modified Mayo wrist score (MMWS) and patient-rated wrist evaluation (PRWE), grip strength, wrist range of motion (ROM), and radiographic parameters such as ulnar variance, the carpal height ratio (CHR), the carpal ulnar distance (CUD), and the radioscaphoid (RS) angle. The union rate, time to union, time to return to work, and incidence of postoperative complications were also recorded.
resultsBoth groups demonstrated significant postoperative improvement in pain (VAS pain score, p = 0.001). At 84 months, the preservation group achieved superior pain control, with a lower mean VAS score (5 versus 12, p = 0.001). The preservation group also maintained a greater CUD (30 mm versus 23 mm, p = 0.001) and exhibited later onset of degenerative changes. MMWS improved from 49 to 73 in the preservation group and from 48 to 72 in the excision group. The PRWE scores decreased from 69 to 21 in the preservation group and from 67 to 24 in the excision group. The final grip strength reached 88% of that of the contralateral side in the preservation group and 84% in the excision group, with no significant difference in ROM. The union rates were 93% for preservation and 91% for excision. The excision group presented higher rates of degenerative changes (16 versus 8 cases) and nonunion (2 versus 1). No major differences were found in the infection rate, sympathetic reflex dystrophy, or return to work.
conclusionsSC arthrodesis provides reliable long-term pain relief in patients with stage IIIB Kienböck's disease. Lunate preservation provides superior pain control and carpal alignment, reduces degenerative sequelae, and is recommended where feasible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.